热门资讯> 正文
Vertex Pharmaceuticals 2026年第二季度盈利预览
2026-05-09 05:35
- Vertex Pharmaceuticals (VRTX) is scheduled to announce Q2 earnings results on Monday, May 11th, after market close.
- The consensus EPS Estimate is $4.75 (+5.1% Y/Y) and the consensus Revenue Estimate is $3.22B (+8.8% Y/Y).
- Over the last 2 years, VRTX has beaten EPS estimates 50% of the time and has beaten revenue estimates 63% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 9 downward. Revenue estimates have seen 8 upward revisions and 4 downward.
- Recent earnings Analysis from our contributors:Vertex Pharmaceuticals Q1 Earnings Review: Pharma May Need Bolder M&A StrategyVertex Pharmaceuticals: Looking For Signs Of Success In Q1 Earnings
More on Vertex Pharmaceuticals
- Vertex Pharmaceuticals Q1 Earnings Review: Pharma May Need Bolder M&A Strategy
- Vertex Pharmaceuticals Incorporated 2026 Q1 - Results - Earnings Call Presentation
- Vertex Pharmaceuticals Incorporated (VRTX) Q1 2026 Earnings Call Transcript
- Vertex projects 2026 revenue of $12.95B-$13.1B while targeting $500M-plus from non-CF products
- Vertex Pharmaceuticals Non-GAAP EPS of $4.47 beats by $0.16, revenue of $2.99B misses by $10M
推荐文章
腾讯、阿里等中概巨头业绩来袭！AI收入转化率成核心看点，这轮财报季能否助力恒科“反弹”？
港股周报 | 存储芯片持续飙升！两倍做多海力士周内狂涨64%；段永平重大调仓！清仓中国神华，大幅买入泡泡玛特
一周财经日历 | 下周重磅大事齐袭！特朗普政府或携黄仁勋访华；中概科网股财报季打响！腾讯、阿里同日放榜
美股机会日报 | “TACO”已经过时？华尔街疯狂涌入“NACHO”交易；今晚20:30！美国4月非农或创年内最大落差？
华盛早报 | 美伊突发交火！特朗普密集发声施压；英伟达官宣入股，IREN盘后一度暴涨27%
5月8日外盘头条：美国计划本周重启护航行动 特朗普给予欧盟至7月4日批准贸易协议 OpenAI与博通芯片豪赌遇冷
CoreWeave一季度末签约总电力容量3.5吉瓦 年内股价涨近80%
马斯克再下注：SpaceX IPO倒计时 拟投1190亿美元建Terafab芯片厂
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
